Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.
Saved in:
| Title: | Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study. |
|---|---|
| Authors: | Lee JY; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea., Choi S; Division of Data Science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jung S; Division of Data Science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Park SS; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea., Shin SH; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jeon YW; Department of Hematology, Yeoido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yahng SA; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea., Kim HJ; Department of Hematology-Oncology, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Republic of Korea., Lee GW; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea., Eom HS; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea., Kim MK; Division of Hemato-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea., Kim Y; Division of Hemato-Oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea., Kwon J; Department of Internal Medicine, Hematology and Oncology, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea., Min CK; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ckmin@catholic.ac.kr. |
| Corporate Authors: | Korean Multiple Myeloma Working Party (KMMWP) |
| Source: | Annals of hematology [Ann Hematol] 2026 Mar 23; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0584 |
|---|---|
| DOI: | 10.1007/s00277-026-06849-w |
